CHINWE EKWEARIRI: Open Payments
NPI 1629552336 · SUGAR LAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$794 in 28 payments from 12 companies in 2025. Trend: 2023 $660 · 2024 $470 · 2025 $794
Food & beverage: $794
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $169 |
| Sumitomo Pharma America, Inc. | 5 | $103 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $82 |
| ABC Home Medical Supply, Inc. | 2 | $77 |
| Janssen Biotech, Inc. | 3 | $74 |
| TOLMAR, INC. | 3 | $64 |
| UROGEN PHARMA, INC. | 1 | $46 |
| Astellas Pharma US Inc | 2 | $43 |
| ABBVIE INC. | 2 | $41 |
| Antares Pharma, Inc. | 2 | $34 |
Products named: General - Erectile Dysfunction, GEMTESA, Nubeqa, ERLEADA, JATENZO, XYOSTED, AQUABEAM ROBOTIC SYSTEM, BARRIGEL.
Industry payments across TX — which companies pay providers there.
